1. Home
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
Hydrocephalus Shunts Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Age Group, Type, Product, and End User

Hydrocephalus Shunts Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Age Group, Type, Product, and End User

  • September 2022
  • 205 pages
  • ID: 6353516
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The hydrocephalus shunts market is expected to grow from US$ 286.19 million in 2021 to US$ 360.01 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the hydrocephalus shunts market growth.The market growth is attributed to the increasing prevalence of hydrocephalus, and advancements in hydrocephalus valves.

However, the high cost of treatments involving shunts and the need for revision surgeries limit the market growth.
Hydrocephalus shunt alludes to a clinical gadget that aids the treatment of a condition in the mind where an exorbitant collection of cerebrospinal liquid occurs.This condition causes expanded intracranial pressing factor in the skull.

These gadgets help in soothing the tension on the cerebrum because of the fluid gathering.
Hydrocephalus is a prime cause of morbidity worldwide, affecting over 1 million people in the United States. According to the National Institute of Neurological Disorders and Stroke (NINDS), hydrocephalus is assumed to affect approximately 1 to 2 in every 1,000 children born in the U.S. As per the Los Angeles Health Organization, the University of California, ~125,000 people in the US are currently living with cerebrospinal fluid shunts.
The majority of hydrocephalus cases are often diagnosed before birth, at the time of delivery, or in early childhood.Hospitals in the US discharge ~69,000 patients annually with a primary diagnosis of hydrocephalus, of which 50% undergo new shunt placement procedures.

Over half of these admissions are classified as urgent or emergencies.The average cost of each treatment is ~US$ 35,816.

As stated in “Hydrocephalus and Shunts,” an article published by Ausmed, ~33,000 people undergo shunt placement surgeries every year in the US. CSF diversion surgeries and shunt revision surgeries, collectively, account for nearly one-third of all neurosurgical procedures annually in the country.
Based on product, the hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others.The hydrocephalus valves are further bifurcated into adjustable pressure valves and fix pressure valves.

The hydrocephalus valves segment held the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period.
Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculoatrial, ventriculo-pleural, and lumbo-peritoneal.In 2021, the ventriculoperitoneal segment held the largest share of the market.

Moreover, the same segment is expected to grow at a significant CAGR during the forecast period.
Based on the age group, the hydrocephalus shunts market is bifurcated into pediatric and adults.In 2021, the pediatric segment held the largest share of the market.

Moreover, the same segment is estimated to grow at a significant CAGR during the forecast period.
Based on the end user, the hydrocephalus shunts market is segmented hospitals, ambulatory surgical centers, and others.The hospitals segment is anticipated to hold the largest market share in 2021.

Moreover, the same segment is expected to register the highest CAGR during the forecast period.
COVID-19 Impact – Hydrocephalus Shunts Market
The growing concern regarding the spread of COVID-19 led a majority of healthcare systems to postpone or cancel non-essential medical procedures in 2020.During the pandemic, there was an unexpected decrease in the number of shunt surgeries performed, particularly in the number of revision surgeries performed.

Several medical device companies either withdrew or revised their financial projections and revenue guidelines for 2020. For Instance, Medtronic predicted a significant negative impact on revenue across major markets due to ~65–85% drop in surgical procedures in the second quarter of 2020.
COVID-19 deranged routine hospital services globally.Hospitals around the world witnessed a huge reduction in elective surgery procedures for ensuring patient safety.

Similarly, the introduction of disruptive technologies, such as “eShunt system,” would propel the growth of the hydrocephalus shunts market post-pandemic.
Various organic and inorganic strategies are adopted by companies in the hydrocephalus shunts market.The organic strategies mainly include product launches and product approvals.

Further, inorganic growth strategies adopted by the market players are acquisitions, collaboration, and partnerships.These growth strategies allow the hydrocephalus shunts market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth.

Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios. A few significant developments by key players in the hydrocephalus shunts market are listed below.
• In May 2020, Aesculap, Inc. launched the M.blue valve in the US, in partnership with Christoph Miethke GmbH & Co. KG (MIETHKE). The M.blue valve features advanced gravitational technology, which is incorporated with a fixed differential pressure unit in one valve.

• In July 2019, Integra LifeSciences announced the acquisition of Arkis Biosciences Inc., a privately held company that offers a portfolio of neurossurgical devices, such as catheters. The acquisition of Arkis Biosciences strengthened Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.

A few of the major primary and secondary sources referred to while preparing the report on the hydrocephalus shunts market are the World Health Organization (WHO), Centers for Disease Control (CDC), and Food and Drug Administration (FDA).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asia-Pacific Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

  • $ 3000
  • November 2022
  • 192 pages

The embolotherapy market in Asia Pacific is expected to grow from US$ 781.80 million in 2022 to US$ 1,272.58 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028. Growing Use of ...

  • APAC
  • Cancer
  • Cardiovascular Disease
  • Industry analysis
  • Chronic Disease Prevalence
  • Health Expenditure


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on